Last updated on January 2010

Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases

Brief description of study

The aim of this study is the identification of familial congenital arrhythmogenic disorders and their clinical follow-up.

Detailed Study Description

Molecular genetic screening in patients with: - supraventricular - ventricular arrhythmia - syncopes of unknown origin and/or suspicion of an arrhythmogenic origin - family members of patients with sudden cardiac death and aborted sudden cardiac death Examination of patients includes routine testing like electrocardiogram (ECG), sequential ECGs, exercise testing, invasive electrophysiological stimulation, cardiac magnetic resonance imaging, intravenous drug challenge for identification/exclusion of eg Brugada syndrome. Examples are patients with Long QT Syndrome, Short QT Syndrome, Brugada Syndrome, familial atrial fibrillation, WPW-syndrome, arrhythmias due to familial hypertrophic cardiomyopathy or arrhythmogenic right ventricular dysplasia. Blood samples are taken for further molecular genetic screening.

Clinical Study Identifier: NCT00221832

Find a site near you

Start Over